PAYS Form 4: CFO exercises & sells; retains 252k shares
Rhea-AI Filing Summary
Paysign, Inc. (PAYS) Form 4 highlights insider activity by CFO Jeffery B. Baker.
- On 07/31/2025 Baker received 64,000 common shares as part of a previously granted restricted stock award; the grant vests 20 % annually from 07/31/2022 through 07/31/2027 and carried a $0 exercise price.
- On 08/04/2025 he sold 30,396 shares at a weighted-average price of $7.0851 (sales occurred within a price range of $6.9976–$7.1530).
Following these transactions Baker directly owns 252,273 common shares and retains derivative rights to 128,000 additional shares tied to the same award. The filing discloses no new option grants, compensation changes or company-specific events and indicates the sale was executed under a Rule 10b5-1 plan. Overall, the activity appears routine, with the executive maintaining a substantial equity stake.
Positive
- CFO retains 252,273 shares post-sale, indicating continued alignment with shareholders.
Negative
- Insider sold 30,396 shares, which some investors may interpret as reduced short-term confidence.
Insights
TL;DR: Routine vesting plus modest sale; neutral insider signal.
The CFO converted 64 k restricted shares and monetised ~47 % of that lot at $7.09. Proceeds are modest and he still controls 252 k shares, preserving meaningful alignment with shareholders. No new awards, no unusual timing, and the trade is flagged as 10b5-1, limiting information-content. Market impact should be minimal unless compounded by other data points.
TL;DR: Governance-clean filing; share sale small vs. holdings.
Because the transaction occurs under a pre-arranged trading plan and within scheduled vesting, the sale raises no governance red flags. Baker’s remaining direct plus derivative holdings (≈380 k shares) continue to link compensation with performance. The pattern is consistent with diversification rather than signalling negative outlook.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 30,396 | $7.0851 | $215K |
| Exercise | Stock Grant | 64,000 | $0.00 | -- |
| Exercise | Common Stock | 64,000 | $0.00 | -- |
Footnotes (1)
- One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9976 to $7.1530, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
